NYU Cancer Institute — New York, New York

NYU Cancer Institute is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

NYU Cancer Institute has participated in 22 clinical trials with 2 currently active.

Therapeutic areas: Colorectal Cancer, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma.

Sponsors: AVEO Pharmaceuticals, Inc., Albert Einstein College of Medicine, National Center for Research Resources (NCRR).

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Cancer Institute?

NYU Cancer Institute has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Cancer Institute conducted?

NYU Cancer Institute has 22 clinical trials on record, with 2 currently active. Their work covers Colorectal Cancer, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma.

Is NYU Cancer Institute accredited by Crixeo Health?

Yes — NYU Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NYU Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.